iSpecimen's Series B Round

iSpecimen raised a round of funding on September 04, 2014. Investors include OneBlood.

iSpecimen, a privately held company, provides life scientists with a rich source of high-quality human biospecimens for their research and development programs. The company's pioneering technology all…

Articles about iSpecimen's Series B Round: